Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, is opening a new distribution center in Greenwood, Indiana. Scheduled to begin operations in 2027, the center will expand Resmed's U.S. presence and strengthen the company's distribution capacity to better serve patients and providers across North America.

GlobeNewsWire • 12 hours ago

Invesco International Growth Fund Q4 2025 Portfolio Update

Invesco International Growth Fund underperformed most in industrials, consumer discretionary and communication services, all due to stock selection. We initiated five positions during the quarter, four of which we can discuss now. We eliminated seven positions. Relative to its index, the fund outperformed most in financials, health care and energy, all due to stock selection.

Seeking Alpha • Feb 16, 2026

Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns

The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. APH, GE, RMD and AMP are some such stocks.

Zacks Investment Research • Feb 9, 2026

RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand

Resmed shares rise after Q2 EPS and revenues beat expectations, with the gross and operating margins expanding sharply across core segments.

Zacks Investment Research • Feb 6, 2026

Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge

Sleep-breathing device maker ResMed plans to take global a doctor education program aimed at promoting the screening of patients seeking Ozempic-style weight loss drugs for apnea, calling the GLP‑1 boom a lift, not a threat, to sales.

Reuters • Feb 3, 2026

4 Medical Product Stocks to Watch From a Challenging Industry (Revised)

The Zacks Medical Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.

Zacks Investment Research • Feb 3, 2026

4 Medical Product Stocks to Watch From a Challenging Industry

The Zacks Medical products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.

Zacks Investment Research • Feb 2, 2026

ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell

ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell

Seeking Alpha • Feb 1, 2026

Analysts Maintain Bull Case On ResMed Despite Competition Concerns

On Thursday, ResMed Inc (NYSE: RMD) reported that second-quarter fiscal 2026 adjusted earnings of 2.81, beating the consensus of $2.72.

Benzinga • Jan 30, 2026

ResMed beats quarterly profit estimates on strong demand for its sleep devices

Medical device maker ResMed on Thursday beat Wall Street estimates for second-quarter profit on the back of strong demand for its devices used to manage sleep apnea.

Reuters • Jan 29, 2026